Arvinas, Inc.
NASDAQ:ARVNBiotechnology
-$0.10 today
- Market cap
- $443.01M
- Beta
- 1.75
- P/E (TTM)
- -2.2
- EPS (TTM)
- -$3.46
Volume 1.09M
Average 0.89M
ARVN Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Arvinas, Inc.NASDAQ: ARVN
Operating Income · Q1 FY2026 · quarter ended Mar 2026
Operating income turns negative
Q1 FY2026 operating income was -$62.7M, compared with $71.4M a year earlier. Trailing-twelve-month operating income was -$249.7M.
Context
- Operating income amounted to 43.8% of revenue in FY2025, down 51.2 pp from a year earlier.
- Operating income grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether operating income reaches the consensus estimate from 10 analysts of $11.08M (+109.6%) for the fiscal year ending Dec 2026, a step up from the +54.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$62.7M+12.6% QoQ
- Last fiscal yearDec 2025
- -$114.9M+54.1% YoY
- LTMMar 2026
- -$249.7M-161.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -187.8% | +65.8% | +253.6 pp |
| 1 year | +54.1% | +109.6% | +55.6 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- (114.9M) USD
- Year-over-year change
- +54.1%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (114.9M) | +54.1% |
| FY2024 | 2024-12-31 | (250.2M) | +37.7% |
| FY2023 | 2023-12-31 | (401.5M) | -52.5% |
| FY2022 | 2022-12-31 | (263.2M) | -39.7% |
| FY2021 | 2021-12-31 | (188.4M) | — |
Operating Income vs competitors
How ARVN compares with its peers on the latest reported figures
- ARVN's LTM Mar 2026 operating income of -$249.7M is the 5th highest of the 6 companies compared; the peer median is -$113.84M.
- Its year-over-year change of -161.2% is the 5th highest of 6, against a peer median of +2.3%.
- Operating income amounts to 279.3% of revenue for ARVN, versus a peer median of 326.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Aug 2026 | $289.66M | +208.4% | — | 41.3% | |
| LTM Mar 2026 | -$80.77M | +17.1% | — | 286.2% | |
| LTM Mar 2026 | -$113.84M | +2.3% | — | 326.6% | |
| LTM Mar 2026 | -$148.28M | -6864.7% | — | 345.2% | |
| LTM Mar 2026 | -$249.7M | -161.2% | — | 279.3% | |
| LTM Jun 2026 | -$350.18M | -12.3% | — | 333.5% | |
| Peer median (excluding ARVN) | -$113.84M | +2.3% | — | 326.6% | |
Competitors are the stored peer set for ARVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 53.6M | 131.4M | 78.5M | 263.4M | 262.6M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 5.2M |
| Gross Profit | 53.6M | 131.4M | 78.5M | 263.4M | 257.4M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 98.0% |
| Research & Development | 180.4M | 315M | 379.7M | 348.2M | 282.9M |
| Selling, General & Admin | 61.6M | 79.6M | 100.3M | 165.4M | 89.4M |
| Operating Expenses | 242M | 394.6M | 480M | 513.6M | 372.3M |
| Depreciation & Amortization | 6M | 8.2M | 6.7M | 6.6M | 5.2M |
| EBITDA | (184.9M) | (253.4M) | (359.7M) | (191.7M) | (75.3M) |
| EBITDA Margin | -345.0% | -192.8% | -458.2% | -72.8% | -28.7% |
| Operating Income | (188.4M) | (263.2M) | (401.5M) | (250.2M) | (114.9M) |
| Operating Margin | -351.5% | -200.3% | -511.5% | -95.0% | -43.8% |
| Interest Income | 1.8M | 12M | 38.8M | 54.8M | 22M |
| Interest Expense | 100K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (2.6M) | 1.6M | 35.1M | 51.9M | 34.4M |
| Income Before Tax | (191M) | (261.6M) | (366.4M) | (198.3M) | (80.5M) |
| Pre-Tax Margin | -356.3% | -199.1% | -466.8% | -75.3% | -30.7% |
| Income Tax Expense | 0 | 20.9M | 900K | 600K | 300K |
| Net Income | (191M) | (282.5M) | (367.3M) | (198.9M) | (80.8M) |
| Net Margin | -356.3% | -215.0% | -467.9% | -75.5% | -30.8% |
| EPS (Basic) | (3.82) | (5.31) | (6.62) | (2.77) | (1.28) |
| EPS (Diluted) | (3.82) | (5.31) | (6.62) | (2.77) | (1.28) |
| Weighted Avg Shares | 50M | 53.2M | 55.5M | 71.9M | 64.9M |
| Weighted Avg Shares (Diluted) | 50M | 53.2M | 55.5M | 71.9M | 64.9M |
Arvinas, Inc.
NASDAQ:ARVN
Intrinsic Alpha fair value
Locked
Current Price
$6.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.